文献速递系统性红斑狼疮

机器学习识别可预测系统性红斑狼疮疾病结局的纵向自身抗体谱聚类

Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
PubMed 文献 · Ann Rheum Dis · 2023-04-21

基于805例系统性红斑狼疮(SLE)患者诊断后15个月内及3年、5年随访的29种抗核抗体荧光模式和20种自身抗体数据,采用主成分分析变换后的K均值聚类识别出4个纵向自身抗体表型聚类。聚类1和聚类3的10年生存率低于聚类2(校正HR分别为2.60和2.87)。4个聚类可预测长期疾病活动度、器官受累、治疗需求和死亡风险。

要点

  • 聚类1(抗Smith、抗U1RNP、AC-5高频率、高ANA滴度)10年累积疾病活动度和免疫抑制剂/生物制剂使用最高。
  • 聚类3(5种抗磷脂抗体频率最高)癫痫发作和低补体血症频率最高,校正HR 2.87生存低于聚类2。
  • 聚类4以多种自身抗体反应性为特征,疾病活动度也高;聚类2疾病活动度、狼疮肾炎和治疗使用最低。

核心结论

  • 4个离散的SLE患者纵向自身抗体聚类可预测长期疾病活动度、器官受累、治疗需求和死亡风险。

研究设计与样本

  • 研究纳入805例SLE患者,采集诊断后15个月内及3年、5年随访的人口学、临床和血清学数据。
  • 每次访视检测29种抗核抗体免疫荧光模式和20种自身抗体,对主成分分析变换后的纵向自身抗体谱进行K均值聚类。
  • 采用单因素方差分析比较聚类入组人口学特征和10年随访临床结局,Cox比例风险模型校正发病年龄后估计生存HR。

主要发现

  • 聚类1(n=137,抗Smith、抗U1RNP、AC-5高频率和高ANA滴度)10年时累积疾病活动度和免疫抑制剂/生物制剂使用最高。
  • 聚类2(n=376,抗双链DNA和ANA滴度低)疾病活动度、狼疮肾炎频率和免疫抑制剂/生物制剂使用最低。
  • 聚类3(n=80,5种抗磷脂抗体频率最高)癫痫发作和低补体血症频率最高。
  • 聚类4(n=212)疾病活动度也高,以抗组蛋白、抗双链DNA、抗核糖体P、抗干燥综合征抗原A或Ro60、抗干燥综合征抗原B或La、抗Ro52/三联基序蛋白21、抗增殖细胞核抗原和抗着丝点蛋白B等多种自身抗体反应性为特征。
  • 与聚类2相比,聚类1校正HR 2.60(95%CI 1.12至6.05,p=0.03)、聚类3校正HR 2.87(95%CI 1.22至6.74,p=0.02)生存较低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: A novel longitudinal clustering technique was applied to comprehensive autoantibody data from a large, well-characterised, multinational inception systemic lupus erythematosus (SLE) cohort to determine profiles predictive of clinical outcomes. METHODS: Demographic, clinical and serological data from 805 patients with SLE obtained within 15 months of diagnosis and at 3-year and 5-year follow-up were included. For each visit, sera were assessed for 29 antinuclear antibodies (ANA) immunofluorescence patterns and 20 autoantibodies. K-means clustering on principal component analysis-transformed longitudinal autoantibody profiles identified discrete phenotypic clusters. One-way analysis of variance compared cluster enrolment demographics and clinical outcomes at 10-year follow-up. Cox proportional hazards model estimated the HR for survival adjusting for age of disease onset. RESULTS: Cluster 1 (n=137, high frequency of anti-Smith, anti-U1RNP, AC-5 (large nuclear speckled pattern) and high ANA titres) had the highest cumulative disease activity and immunosuppressants/biologics use at year 10. Cluster 2 (n=376, low anti-double stranded DNA (dsDNA) and ANA titres) had the lowest disease activity, frequency of lupus nephritis and immunosuppressants/biologics use. Cluster 3 (n=80, highest frequency of all five antiphospholipid antibodies) had the highest frequency of seizures and hypocomplementaemia. Cluster 4 (n=212) also had high disease activity and was characterised by multiple autoantibody reactivity including to antihistone, anti-dsDNA, antiribosomal P, anti-Sjögren syndrome antigen A or Ro60, anti-Sjögren syndrome antigen B or La, anti-Ro52/Tripartite Motif Protein 21, antiproliferating cell nuclear antigen and anticentromere B). Clusters 1 (adjusted HR 2.60 (95% CI 1.12 to 6.05), p=0.03) and 3 (adjusted HR 2.87 (95% CI 1.22 to 6.74), p=0.02) had lower survival compared with cluster 2. CONCLUSION: Four discrete SLE patient longitudinal autoantibody clusters were predictive of long-term disease activity, organ involvement, treatment requirements and mortality risk.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Choi MY, Chen I, Clarke AE, et al. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. Ann Rheum Dis. 2023. PMID: 37085289. doi:10.1136/ard-2022-223808

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。